Market Overview

Stocks Hitting 52-Week Highs

Share:
Related CSII
Why JMP Securities Is Watching (And Loving) These 3 Biotech Stocks
How To Profit From An Aging Population
Related BMRN
Is BioMarin Still An Outperform At This Research Firm?
BioMarin Completes Rolling NDA Submission to FDA for Drisapersen for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
Premarket Gainers / Losers as of 9:10 am (Seeking Alpha)

Cardiovascular Systems (NASDAQ: CSII) shares jumped 0.89% to create a new 52-week high of $12.50. Cardiovascular Systems reported a 25% surge in its FQ1 revenue.

BioMarin Pharmaceutical (NASDAQ: BMRN) shares gained 27.75% to touch a new 52-week high of $47.79. BioMarin Pharmaceutical reported that the pivotal Phase 3 study of GALNS for the treatment of MPS IVA met the primary endpoint.

Tekmira Pharmaceuticals (NASDAQ: TKMR) shares rose 5.16% to create a new 52-week high of $4.45. Tekmira's stock has a 52-week low of $1.29.

Huntsman (NYSE: HUN) shares gained 3.77% to create a new 52-week high of $16.80. Huntsman has priced a $400 million offering of senior notes due 2020.

Posted-In: 52-Week HighsNews Intraday Update Markets Movers

 

Related Articles (BMRN + CSII)

Around the Web, We're Loving...